Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation.
Mori T, Verma R, Nakamoto-Matsubara R, Siu KT, Panaroni C, Fulzele KS, Mukaihara K, Onyewadume C, Maebius A, Kato H, Wong LP, Sadreyev RI, Scadden DT, Raje NS.
Mori T, et al. Among authors: siu kt.
Blood Cancer J. 2021 Dec 4;11(12):194. doi: 10.1038/s41408-021-00589-y.
Blood Cancer J. 2021.
PMID: 34864816
Free PMC article.